+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point of Care Diagnostics Market - Global Forecast 2026-2032- Product Image
Point of Care Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Point of Care Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090446
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Point of Care Diagnostics Market is projected to reach USD 52.39 Billion in 2026. It is expected to continue growing at a CAGR of 8.10%, reaching USD 83.86 Billion by 2032.

Point-of-Care Diagnostics: Executive Summary

Point-of-care diagnostics (POCD) encompass tests performed near or at the patient rather than exclusively in centralized laboratories. The field includes rapid infectious-disease testing, blood-glucose monitoring, pregnancy testing, cardiac and critical-care assays, molecular platforms, and other decentralized diagnostic applications. Its strategic importance is linked to faster clinical decisions, improved access, and the growing need to extend diagnostic capacity beyond hospitals and reference laboratories.

Decentralization, Connectivity, and Workflow Integration Are Reshaping POCD

The landscape is shifting from standalone rapid tests toward connected diagnostic workflows that combine portable instruments, disposable assays, digital records, remote oversight, and clinical decision support. Demand is being influenced by hospital overcrowding, decentralized care, chronic-disease management, emergency response, and the need for testing in pharmacies, clinics, ambulances, workplaces, and community settings. Regulatory scrutiny, quality assurance, operator training, reimbursement alignment, and interoperability remain essential to converting technical capability into dependable clinical value.

Artificial Intelligence Is Strengthening Interpretation, Triage, and Quality Control

Artificial intelligence is being applied to interpret complex signals, prioritize abnormal results, support image-based diagnostics, identify testing errors, and assist clinicians in triage. Its greatest near-term contribution is likely to come from augmenting trained users rather than replacing them, particularly where results require contextual interpretation or integration with patient histories. Successful deployment depends on representative validation data, transparent performance monitoring, cybersecurity, privacy safeguards, human oversight, and clear accountability when algorithmic recommendations influence care.

Regional Insights: Access Priorities Differ Across Six Broad Geographies

North America emphasizes connected care, regulatory compliance, hospital efficiency, and chronic-disease monitoring. Europe combines strong laboratory standards with interest in decentralized services, cross-border data governance, and integrated health systems. Asia-Pacific spans advanced digital-health ecosystems and substantial access gaps, creating demand for portable, robust, and easy-to-use platforms. Latin America prioritizes affordability, decentralized screening, and continuity of care across uneven infrastructure. The Middle East is investing in modern healthcare networks, emergency readiness, and technology-enabled services, while Africa places particular emphasis on rugged platforms, supply-chain resilience, community-based delivery, and workforce enablement.

Group Insights: Policy and Economic Blocs Shape Adoption Conditions

ASEAN countries share priorities around infectious-disease preparedness, distributed care, and solutions suited to varied health-system capacity. BRICS members reflect diverse approaches to domestic manufacturing, affordability, public-sector procurement, and broad population access. The European Union places weight on safety, evidence, interoperability, and data governance across member states. G7 markets generally emphasize advanced clinical integration, cybersecurity, validation, and efficiency in mature health systems. GCC countries are pursuing digitally enabled healthcare modernization and centralized procurement capabilities. NATO members also have an interest in resilient medical logistics, emergency preparedness, and interoperable response systems, although adoption conditions vary by national health policy.

Country Insights: National Health Priorities Define POCD Opportunities

Australia is suited to decentralized testing because of geographic dispersion and remote-care requirements. Brazil and Mexico face opportunities in primary care, infectious-disease screening, and access across regional health disparities. Canada’s geography supports remote diagnostics and connected services. China is advancing domestic capability, hospital digitization, and broad healthcare access, while India emphasizes affordability, scale, primary care, and community deployment. Japan and South Korea combine sophisticated healthcare infrastructure with strong interest in automation and aging-related care. France, Germany, Italy, Spain, and the United Kingdom are shaped by public-health systems, evidence requirements, workforce pressures, and care integration. Russia’s environment is influenced by domestic supply considerations and geographically distributed service needs. The United States emphasizes decentralized testing, clinical workflow integration, regulatory evidence, and home-based monitoring.

Actions for Leaders: Build Trustworthy, Interoperable, and Deployable Solutions

Industry leaders should prioritize clearly defined clinical use cases and design products around real workflows rather than laboratory performance alone. Evidence plans should address analytical validity, clinical utility, usability, operator variability, and performance across relevant populations. Interoperability with electronic health records, secure connectivity, remote quality control, and transparent reporting can improve adoption. Organizations should also strengthen supply-chain resilience, provide structured training, support maintenance in low-resource settings, and align commercial models with reimbursement and public procurement. AI-enabled products require continuous monitoring, bias assessment, explainability appropriate to the use case, and explicit human escalation pathways.

Research Methodology: Evidence-Led Assessment of a Diverse Diagnostic Field

This executive summary uses a structured assessment of point-of-care diagnostics across technologies, clinical applications, care settings, stakeholders, and geographies. The approach distinguishes verified operational, clinical, regulatory, and adoption trends from unsupported claims. Regional, group, and country perspectives are synthesized from established healthcare-system characteristics, public policy priorities, diagnostic-access conditions, and technology adoption patterns. Interpretations are framed qualitatively, with no market estimates, sizing, shares, or forecasts, and should be complemented by current regulatory documents, peer-reviewed evidence, procurement records, and local clinical guidance when used for decisions.

Conclusion: POCD Value Depends on Clinical Reliability and System Fit

Point-of-care diagnostics are becoming an important component of distributed healthcare, but their impact depends on more than speed or portability. Reliable results, appropriate clinical governance, connected workflows, equitable access, and sustainable support determine whether decentralized testing improves care. Leaders that combine validated technology with strong implementation, data stewardship, workforce enablement, and regional responsiveness will be better positioned to deliver dependable diagnostic value across hospitals, communities, and homes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Point of Care Diagnostics Market, by Product
7.1. Introduction
7.2. Consumables
7.2.1. Assay Kits
7.2.2. Reagents
7.2.3. Test Strips
7.3. Instruments
7.3.1. Benchtop Analyzers
7.3.2. Handheld Analyzers
7.3.3. Portable Readers
8. Point of Care Diagnostics Market, by Technology
8.1. Introduction
8.2. Biosensors
8.2.1. Electrochemical
8.2.2. Optical
8.3. Immunoassay
8.3.1. Chemiluminescence
8.3.2. Fluorescence
8.3.3. Lateral Flow
8.4. Molecular
8.4.1. Isothermal Amplification
8.4.2. Pcr
9. Point of Care Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Saliva
9.4. Urine
10. Point of Care Diagnostics Market, by Mode Of Testing
10.1. Introduction
10.2. Instrument Based
10.3. Microfluidic Chips
10.4. Strip Based
11. Point of Care Diagnostics Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Coagulation
11.4. Diabetes Monitoring
11.5. Infectious Diseases
11.5.1. Bacterial
11.5.2. Parasitic
11.5.3. Viral
11.6. Pregnancy & Fertility
12. Point of Care Diagnostics Market, by End User
12.1. Introduction
12.2. Ambulatory Centers
12.3. Clinics
12.4. Home Healthcare
12.5. Hospitals
13. Point of Care Diagnostics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Point of Care Diagnostics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Point of Care Diagnostics Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. Russia
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. France
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abaxis, Inc.
17.2. Abbott Laboratories
17.3. Becton, Dickinson and Company
17.4. Bio-Rad Laboratories, Inc.
17.5. bioMérieux SA
17.6. Biosynex SA
17.7. Cardinal Health, Inc.
17.8. Chembio Diagnostic Systems, Inc.
17.9. Danaher Corporation
17.10. EKF Diagnostics Holdings plc
17.11. F. Hoffmann-La Roche Ltd
17.12. Helena Laboratories Corporation
17.13. Illumina, Inc.
17.14. Microlife Corporation
17.15. Nova Biomedical Corporation
17.16. QIAGEN N.V.
17.17. Quest Diagnostics Incorporated
17.18. QuidelOrtho Corporation
17.19. Radiometer Medical ApS
17.20. Sekisui Diagnostics LLC
17.21. Siemens Healthineers AG
17.22. Sysmex Corporation
17.23. Thermo Fisher Scientific Inc.
17.24. Trinity Biotech plc
17.25. Werfen, S.A.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Point of Care Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Point of Care Diagnostics Market, Research Design
FIGURE 3. Global Point of Care Diagnostics Market, Research Framework
FIGURE 4. Global Point of Care Diagnostics Market, Data Triangulation
FIGURE 5. Global Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Point of Care Diagnostics Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Point of Care Diagnostics Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Point of Care Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Point of Care Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Point of Care Diagnostics Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Point of Care Diagnostics Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Point of Care Diagnostics Market Size, by Mode Of Testing, 2025 vs 2032 (%)
FIGURE 13. Global Point of Care Diagnostics Market Size, by Mode Of Testing, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Point of Care Diagnostics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Point of Care Diagnostics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Point of Care Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Point of Care Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Point of Care Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Point of Care Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Point of Care Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Point of Care Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Point of Care Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Point of Care Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Point of Care Diagnostics Market Segmentation & Coverage
TABLE 2. Global Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Test Strips Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Test Strips Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Test Strips Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Benchtop Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Benchtop Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Benchtop Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Handheld Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Handheld Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Handheld Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Portable Readers Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Portable Readers Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Portable Readers Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 29. Global Biosensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Biosensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Biosensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Electrochemical Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Electrochemical Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Electrochemical Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Optical Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Optical Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Optical Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Chemiluminescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Chemiluminescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Chemiluminescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Fluorescence Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Fluorescence Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Fluorescence Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lateral Flow Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lateral Flow Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lateral Flow Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Molecular Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Molecular Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Molecular Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 60. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 70. Global Instrument Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Instrument Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Instrument Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Microfluidic Chips Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Microfluidic Chips Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Microfluidic Chips Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Strip Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Strip Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Strip Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Coagulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Coagulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Coagulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Diabetes Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Diabetes Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Diabetes Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Pregnancy & Fertility Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Pregnancy & Fertility Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Pregnancy & Fertility Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Global Ambulatory Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Ambulatory Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Ambulatory Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. North America Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. North America Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 133. North America Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 134. North America Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 135. North America Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 136. North America Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 137. North America Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 138. North America Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 139. North America Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 140. North America Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 141. North America Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. North America Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 143. North America Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Latin America Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Latin America Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 146. Latin America Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 147. Latin America Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 148. Latin America Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 149. Latin America Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 150. Latin America Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 151. Latin America Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 152. Latin America Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 153. Latin America Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 154. Latin America Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Latin America Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 156. Latin America Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Europe Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Europe Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 159. Europe Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 160. Europe Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 161. Europe Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 162. Europe Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 163. Europe Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 164. Europe Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 165. Europe Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 166. Europe Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 167. Europe Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Europe Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 169. Europe Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Middle East Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Middle East Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 172. Middle East Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 173. Middle East Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 174. Middle East Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 175. Middle East Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 176. Middle East Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 177. Middle East Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 178. Middle East Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 179. Middle East Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 180. Middle East Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. Middle East Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 182. Middle East Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Africa Point of Care Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Africa Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 185. Africa Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 186. Africa Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 187. Africa Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. Africa Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 189. Africa Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 190. Africa Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 191. Africa Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 192. Africa Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 193. Africa Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Africa Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 195. Africa Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Global Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. ASEAN Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 199. ASEAN Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 200. ASEAN Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 201. ASEAN Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. ASEAN Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 203. ASEAN Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 204. ASEAN Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 205. ASEAN Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. ASEAN Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 207. ASEAN Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. ASEAN Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 209. ASEAN Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. GCC Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. GCC Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 212. GCC Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 213. GCC Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 214. GCC Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. GCC Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 216. GCC Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 217. GCC Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 218. GCC Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. GCC Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 220. GCC Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. GCC Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 222. GCC Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. European Union Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. European Union Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 225. European Union Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 226. European Union Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 227. European Union Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. European Union Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 229. European Union Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 230. European Union Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 231. European Union Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 232. European Union Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 233. European Union Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. European Union Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 235. European Union Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. BRICS Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. BRICS Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 238. BRICS Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 239. BRICS Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 240. BRICS Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 241. BRICS Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 242. BRICS Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 243. BRICS Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 244. BRICS Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 245. BRICS Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 246. BRICS Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. BRICS Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 248. BRICS Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. G7 Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. G7 Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 251. G7 Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 252. G7 Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 253. G7 Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. G7 Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 255. G7 Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 256. G7 Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 257. G7 Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 258. G7 Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 259. G7 Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. G7 Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 261. G7 Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. NATO Point of Care Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. NATO Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 264. NATO Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 265. NATO Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 266. NATO Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. NATO Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 268. NATO Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 269. NATO Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 270. NATO Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 271. NATO Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 272. NATO Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. NATO Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 274. NATO Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. Global Point of Care Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 276. United States Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 277. United States Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 278. United States Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 279. United States Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 280. United States Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 281. United States Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 282. United States Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 283. United States Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 284. United States Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 285. United States Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 286. United States Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. United States Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 288. United States Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. China Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 290. China Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 291. China Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 292. China Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 293. China Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. China Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 295. China Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 296. China Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 297. China Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 298. China Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 299. China Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. China Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 301. China Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. Germany Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 303. Germany Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 304. Germany Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 305. Germany Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 306. Germany Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 307. Germany Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 308. Germany Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 309. Germany Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 310. Germany Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 311. Germany Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 312. Germany Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. Germany Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 314. Germany Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. United Kingdom Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 316. United Kingdom Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 317. United Kingdom Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 318. United Kingdom Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 319. United Kingdom Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 320. United Kingdom Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 321. United Kingdom Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 322. United Kingdom Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 323. United Kingdom Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 324. United Kingdom Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 325. United Kingdom Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. United Kingdom Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 327. United Kingdom Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 328. India Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 329. India Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 330. India Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 331. India Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 332. India Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 333. India Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 334. India Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 335. India Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 336. India Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 337. India Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 338. India Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 339. India Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 340. India Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. Japan Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 342. Japan Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 343. Japan Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 344. Japan Point of Care Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 345. Japan Point of Care Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 346. Japan Point of Care Diagnostics Market Size, by Biosensors, 2017-2032 (USD Million)
TABLE 347. Japan Point of Care Diagnostics Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 348. Japan Point of Care Diagnostics Market Size, by Molecular, 2017-2032 (USD Million)
TABLE 349. Japan Point of Care Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 350. Japan Point of Care Diagnostics Market Size, by Mode Of Testing, 2017-2032 (USD Million)
TABLE 351. Japan Point of Care Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 352. Japan Point of Care Diagnostics Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 353. Japan Point of Care Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 354. Russia Point of Care Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 355. Russia Point of Care Diagnostics Market Size, by Product, 2017-2032 (USD Million)
TABLE 356. Russia Point of Care Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 357. Russia Point of Care Diagnos

Companies Mentioned

  • Abaxis, Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Biosynex SA
  • Cardinal Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd
  • Helena Laboratories Corporation
  • Illumina, Inc.
  • Microlife Corporation
  • Nova Biomedical Corporation
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Radiometer Medical ApS
  • Sekisui Diagnostics LLC
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Werfen, S.A.

Related Topics

Related Reports

Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User - Global Forecast to 2031 - Product Image

Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User - Global Forecast to 2031

  • Report
  • 548 Pages
  • Global
From
United States Point of Care Diagnostics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Image

United States Point of Care Diagnostics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • 80 Pages
  • United States
From
North America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By Type, By End-use (Clinics, Home Care, Hospitals), By Country, And Segment Forecasts, 2023 - 2030 - Product Image

North America Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By Type, By End-use (Clinics, Home Care, Hospitals), By Country, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • North America
From
Primary Care PoC Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Mode, End User - Product Image

Primary Care PoC Diagnostics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Mode, End User

  • Report
  • 160 Pages
  • Global
From
Point of Care Testing Market - Global Forecast 2026-2032 - Product Image

Point of Care Testing Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.